Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy PhaseBio Pharmaceuticals stock
Learn how to easily invest in PhaseBio Pharmaceuticals stock.
PhaseBio Pharmaceuticals Inc is a biotechnology business based in the US. PhaseBio Pharmaceuticals shares (PHAS) are listed on the NASDAQ and all prices are listed in US Dollars. PhaseBio Pharmaceuticals employs 60 staff and has a trailing 12-month revenue of around $818,000.
How to buy shares in PhaseBio Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PHAS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
PhaseBio Pharmaceuticals stock price (NASDAQ: PHAS)Use our graph to track the performance of PHAS stocks over time.
PhaseBio Pharmaceuticals shares at a glance
|Latest market close||$0.80|
|52-week range||$0.50 - $4.10|
|50-day moving average||$1.10|
|200-day moving average||$1.32|
|Wall St. target price||$13.67|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.38|
Buy PhaseBio Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy PhaseBio Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
PhaseBio Pharmaceuticals price performance over time
|1 week (2022-09-16)||-20.00%|
|1 month (2022-08-25)||-35.48%|
|3 months (2022-06-24)||17.66%|
|6 months (2022-03-24)||-33.33%|
|1 year (2021-09-24)||-73.60%|
|2 years (2020-09-25)||-76.61%|
|3 years (2019-09-25)||4.84|
|5 years (2017-09-21)||N/A|
PhaseBio Pharmaceuticals financials
|Gross profit TTM||$-91,276,000|
|Return on assets TTM||-106.07%|
|Return on equity TTM||-3091.02%|
|Market capitalisation||$39.7 million|
TTM: trailing 12 months
PhaseBio Pharmaceuticals share dividends
We're not expecting PhaseBio Pharmaceuticals to pay a dividend over the next 12 months.
PhaseBio Pharmaceuticals share price volatility
Over the last 12 months, PhaseBio Pharmaceuticals's shares have ranged in value from as little as $0.5 up to $4.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PhaseBio Pharmaceuticals's is 2.4498. This would suggest that PhaseBio Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.
PhaseBio Pharmaceuticals overview
PhaseBio Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiovascular diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical trial for patients with uncontrolled major or life-threatening bleeding events or in patients requiring urgent or an invasive procedure. The company is also developing PB1046, a vasoactive intestinal peptide analogue for the treatment of pulmonary arterial hypertension; and PB6440 for the treatment of resistant hypertension. The company has a co-development agreement with SFJ Pharmaceuticals X, Ltd. to develop PB2452, a reversal agent for the antiplatelet drug ticagrelor. PhaseBio Pharmaceuticals, Inc.
Frequently asked questionsWhat percentage of PhaseBio Pharmaceuticals is owned by insiders or institutions?
Currently 6.746% of PhaseBio Pharmaceuticals shares are held by insiders and 55.508% by institutions. How many people work for PhaseBio Pharmaceuticals?
Latest data suggests 60 work at PhaseBio Pharmaceuticals. When does the fiscal year end for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals's fiscal year ends in December. Where is PhaseBio Pharmaceuticals based?
PhaseBio Pharmaceuticals's address is: 1 Great Valley Parkway, Malvern, PA, United States, 19355 What is PhaseBio Pharmaceuticals's ISIN number?
PhaseBio Pharmaceuticals's international securities identification number is: US7172241090 What is PhaseBio Pharmaceuticals's CUSIP number?
PhaseBio Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 717224109
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert